Current Status on CM for Biologics: Development to Clinical
Speakers will provide insights on the current stage of deployment of CM for biological molecule clinical manufacturing from the point of view of process technologies, facility assets, and manufacturing operations. Examples of successes as well as challenges encountered will be shared.
The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering AstraZeneca
Perspectives on the Development of Continuous Manufacturing for Biological Products
Mark Brower, Principal Scientist
Novel Technologies to Enable Continuous Manufacturing of Biologics
Govind Rao, PhD, Director, Center for Advanced Sensor Technology
University of Maryland, Baltimore County